Overview

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

Status:
Recruiting
Trial end date:
2030-12-30
Target enrollment:
Participant gender:
Summary
Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome
Phase:
Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Alverine
Ethosuximide
Mebeverine
Pentoxifylline